Over the last 20 years, IMIM (Hospital del Mar Research Institute), a subsidiary of the Parc de Salut MAR, has developed a competitive research programme, and trained highly qualified research personnel in the fields of biomedicine and health sciences. The centre is run by Pompeu Fabra University (UPF), and since October 2006, has been located in the Barcelona Biomedical Research Park (PRBB).

Between the hired personnel and the contributors, the centre is made up of over 350 people, including IMIM researchers and clinical researchers from Parc de Salut Mar centres, particularly from the Hospital del Mar, the Hospital de la Esperanza and the Centro Fórum. An important part of its budget comes from external competitive financing, which are managed by the The Mar Institute of Medical Research Foundation (IMIM).

Our research is categorised into five multidisciplinary programmes, organised around the following themes:

• Cancer, directed by Joan Albanell 
• Epidemiology and Public Health, directed by Jordi Alonso 
• Cardiovascular and inflammatory processes, directed by Jaume Marrugat 
• Biomedical Informatics, directed by Ferran Sanz 
• Neurosciences, directed by Rafael de la Torre

The scientific production generated as a result of this research includes nearly 400 annual publications in international journals listed in the Science Citation Index (SCI) and the Social Sciences Citation Index (SSCI), and some 200 in nationwide journals. This scientific production situates IMIM in eighth position in the ranking of centres with the highest scientific production in biomedicine in Spain, and in fourth position in Catalonia. Additionally, the IMIM is the Spanish healthcare research centre that publishes the largest proportion of work with international collaborations

Scientific Advisory Board (SAB)

Presentation

The Scientific Advisory Board (SAB) of IMIM is constituted by a prestigious group of international scientists, experts in different areas corresponding to the research programs of IMIM.

Composition

President

Alberto Mantovani M.D. Professor of General Pathology, State University of Milan. Scientific Director, Istituto Clinico Humanitas (Rozzano, Milan, Italy).

Co-president

Rémi Quirion Ph.D. Professor, Dpt. of Psychiatry, McGill University. Scientific Director, Mental Health University Institute, Douglas Hospital Research Centre. (Montreal, Canada).

Members

John Kane M.D. Chairman, Department of Psychiatry, The Zucker Hillside Hospital. Professor of Psychiatry, Neurology and Neuroscience, The Albert Einstein College of Medicine (New York, USA).

Jean Ferrières M.D. MSc. Professor of Medicine, Research Director, Toulouse University School of Medicine. Head of the Preventive Cardiology Clinic, Toulouse University Hospital (Toulouse, France).

Jorge Reis-Filho M.D., Ph.D., FRCPath. Team leader, Molecular Pathology Laboratory. The Breakthrough Breast Cancer Research Centre at the Institute of Cancer Research (London, UK).

Rodolfo Saracci M.D. Honorary Director of Research in Epidemiology, Institute of Clinical Physiology, National Research Council (Pisa, Italy).Adjunt Professor of Epidemiology, University of Aarhus (Denmark).

Søren Brunak Ph.D. Professor of Bioinformatics, Dpt. of Systems Biology, Center for Biological Sequence Analysis, Technical University of Denmark (Lyngby, Denmark).

Tudor Oprea M.D. PhD. Professor of Biochemistry and Molecular Biology. Chief, Division of Biocomputing, University of New Mexico School of Medicine, (Albuquerque, USA)